Vaginal Tumors

Focused Ultrasound Therapy

Clinical Trials SquareFocused ultrasound is an early-stage, non-invasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with vaginal tumors. This novel technology focuses beams of ultrasound energy precisely and accurately on targets in the body without damaging surrounding normal tissue. Where the beams converge, the ultrasound produces precise ablation (thermal destruction of tissue) enabling vaginal tumors to be treated without surgery.

The most common option for treatment of vaginal cancer is surgery, but chemotherapy and radiation therapy may also be used. For certain patients, focused ultrasound could provide a non-invasive alternative with less risk of complications and lower cost.

Advantages:

  • Focused ultrasound is a noninvasive treatment, without wound healing and infection concerns.
  • Focused ultrasound not require anesthesia.
  • It is repeatable, if needed.

Clinical Trials

There is a clinical trial assessing focused ultrasound to treat symptomatic (pain or bleeding) recurrent pelvic malignancy when conventional treatment options are not available. 

There is a second clinical trial for recurrent pelvic cancer using the endoluminal focused ultrasound.

For a full list of vaginal tumor clinical trials, please see here.

Regulatory Approval and Reimbursement

Focused ultrasound treatment for vaginal tumors is not yet approved by regulatory bodies or covered by medical insurance companies.

Notable Papers

Abel M, Ahmed H, Leen E, Park E, Chen M, Wasan H, Price P, Monzon L, Gedroyc W, Abel P. Ultrasound-guided trans-rectal high-intensity focused ultrasound (HIFU) for advanced cervical cancer ablation is feasible: a case report. J Ther Ultrasound. 2015 Dec 18;3:21. doi: 10.1186/s40349-015-0043-6. eCollection 2015.